Joshua Salomon | Academic Influence

Joshua Salomon's AcademicInfluence.com Rankings

Joshua Salomon

Philosophy

#6409

World Rank

#9443

Historical Rank

Logic

#3583

World Rank

#4770

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Joshua Salomon's Degrees

Bachelors Biology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Joshua Salomon Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Joshua A. Salomon is Professor of Health Policy at the Stanford University School of Medicine, where he is also director of the Prevention Policy Modeling Lab. He previously served as Professor of Global Health at the Harvard T.H. Chan School of Public Health.

(See a Problem?)

Joshua Salomon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (11746)
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (9252)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (8152)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (7185)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (5789)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (5270)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2015) (4436)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4388)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4293)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (4169)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (2015) (4152)
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. (2017) (4063)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study (2017) (3582)
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (3330)
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 (2017) (2357)
The Global Burden of Cancer 2013. (2015) (2336)
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. (2013) (2142)
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (2016)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. (2016) (1888)
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (1869)
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition (2015) (1618)
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (1580)
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (1515)
Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2018) (1481)
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (1477)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1475)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level (2017) (1311)
High-quality health systems in the Sustainable Development Goals era: time for a revolution (2018) (1306)
Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014) (1271)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1241)
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 (2012) (1159)
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 (2017) (1090)
Enhancing the Validity and Cross-Cultural Comparability of Measurement in Survey Research (2003) (1041)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 (2019) (1041)
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2018) (934)
GBD 2010: design, definitions, and metrics (2012) (908)
Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010 (2012) (894)
The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States (2018) (866)
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014) (853)
Disability weights for the Global Burden of Disease 2013 study. (2015) (750)
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016 (2018) (724)
Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014) (673)
Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement (2016) (630)
Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (623)
Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications (2002) (613)
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2018) (588)
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (579)
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 (2016) (549)
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 (2020) (522)
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (495)
GLOBAL, REGIONAL, AND COUNTRY-SPECIFIC LIFETIME RISK OF STROKE, 1990–2016 (2018) (453)
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015 (2017) (452)
Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries (2018) (431)
Healthy life expectancy in 191 countries, 1999 (2001) (429)
A critical examination of summary measures of population health. (2000) (400)
Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 (2016) (394)
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa (2012) (381)
Global Burden of Disease 2005: call for collaborators (2007) (363)
Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes (2004) (361)
Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries (2005) (301)
Five insights from the Global Burden of Disease Study 2019 (2020) (291)
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (2017) (280)
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (279)
Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (2019) (273)
Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. (2003) (269)
The global burden of tuberculosis: results from the Global Burden of Disease Study 2015 (2017) (264)
The Burden of Cardiovascular Diseases Among US States, 1990-2016 (2018) (249)
The burden of disease and injury in the United States 1996 (2006) (227)
Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. (2008) (226)
Household and community socioeconomic and environmental determinants of child nutritional status in Cameroon (2006) (223)
Child and Adolescent Health From 1990 to 2015 (2017) (217)
Can we reverse the HIV/AIDS pandemic with an expanded response? (2002) (209)
Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation (2012) (207)
Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. (2008) (207)
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. (2014) (205)
Causes of deaths in children younger than 5 years in China in 2008 (2010) (197)
Population health metrics: crucial inputs to the development of evidence for health policy (2003) (190)
Integrating HIV Prevention and Treatment: From Slogans to Impact (2005) (181)
GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology (2012) (178)
The Epidemiologic Transition Revisited: Compositional Models for Causes of Death by Age and Sex (2002) (174)
A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. (2015) (174)
National burden of disease Studies: a practical guide. Global Program on Evidence for Health Policy (2001) (169)
Cost-effectiveness of HPV 16, 18 vaccination in Brazil. (2007) (163)
Are Americans Feeling Less Healthy? The Puzzle of Trends in Self-rated Health (2009) (162)
WHO Multi-country Survey Study on Health and Responsiveness 2000-2001 (2001) (160)
Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment (2007) (154)
Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 (2019) (140)
The Global Impact of Scaling Up HIV/AIDS Prevention Programs in Low- and Middle-Income Countries (2006) (138)
Priority setting for health interventions in Mexico's System of Social Protection in Health (2006) (136)
Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis (2010) (135)
Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models (2016) (134)
Assessing disability weights based on the responses of 30,660 people from four European countries (2015) (132)
Empirically calibrated model of hepatitis C virus infection in the United States. (2002) (132)
Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis (2006) (127)
World mortality in 2000: life tables for 191 countries. (2002) (123)
The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes (2014) (122)
Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates (2006) (118)
Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data (2003) (111)
Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study (2018) (111)
Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination (2007) (110)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 (2016) (110)
Cohort Profile: Health and Ageing in Africa: a Longitudinal Study of an INDEPTH Community in South Africa (HAALSI). (2018) (109)
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 (2021) (108)
The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection (2015) (107)
Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries. (2016) (107)
Global patterns of healthy life expectancy in the year 2002 (2004) (104)
Estimating the Net Effect of HIV on Child Mortality in African Populations Affected by Generalized HIV Epidemics (2005) (100)
Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement (2016) (99)
Health impacts of macroeconomic crises and policies: determinants of variation in childhood malnutrition trends in Cameroon. (2006) (98)
Prospects for Advancing Tuberculosis Control Efforts through Novel Therapies (2006) (97)
Effects of healthcare reforms on coverage, access, and disparities: quasi-experimental analysis of evidence from Massachusetts. (2011) (88)
Stopping tuberculosis: a biosocial model for sustainable development (2015) (86)
A multi-method approach to measuring health-state valuations. (2004) (85)
Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009 (2010) (81)
Statistical Models for Enhancing Cross-Population Comparability (2002) (80)
Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys. (2017) (78)
Disability-Adjusted Life Years (2014) (77)
Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis (2012) (76)
Behaviors of low-income mothers related to fruit and vegetable consumption. (2000) (76)
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. (2016) (74)
New disability weights for the global burden of disease. (2010) (73)
Progress and challenges in modelling country-level HIV/AIDS epidemics: the UNAIDS Estimation and Projection Package 2007 (2008) (73)
Enhancing the Validity and Cross-cultural Comparability of Survey Research 1 (2002) (73)
Health-state valuations for pertussis: methods for valuing short-term health states (2005) (73)
Modelling HIV/AIDS epidemics in sub-Saharan Africa using seroprevalence data from antenatal clinics. (2001) (73)
Life tables for 191 countries for 2000: Data, methods, results (2003) (70)
Illness Transmission in the Home: A Possible Role for Alcohol-Based Hand Gels (2005) (69)
When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs (2017) (69)
Modeling Ranking, Time Trade-Off, and Visual Analog Scale Values for EQ-5D Health States: A Review and Comparison of Methods (2009) (68)
Cost-effectiveness of Rotavirus vaccination in Vietnam (2009) (67)
Enhancing the Validity and Cross-Cultural Comparability of Measurement in Survey Research (2003) (66)
More Evidence on the Impact of India's Conditional Cash Transfer Program, Janani Suraksha Yojana: Quasi-Experimental Evaluation of the Effects on Childhood Immunization and Other Reproductive and Child Health Outcomes (2014) (66)
Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California. (2021) (66)
A Risk‐Based Method for Modeling Traffic Fatalities (2007) (66)
Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. (2018) (65)
Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves. (2007) (62)
Impact of a Text-Messaging Program on Adolescent Reproductive Health: A Cluster-Randomized Trial in Ghana. (2017) (62)
Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3 (2020) (60)
Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply (2021) (58)
Sexual Behaviors and HIV Status: A Population-Based Study Among Older Adults in Rural South Africa (2016) (55)
Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea (2017) (54)
The household secondary attack rate of SARS-CoV-2: A rapid review. (2020) (54)
Estimating distributions of health state severity for the global burden of disease study (2015) (54)
Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States (2018) (53)
Chronic multimorbidity among older adults in rural South Africa (2019) (52)
Future Directions for Cost-effectiveness Analyses in Health and Medicine (2018) (52)
Prevention and treatment of human immunodeficiency virus/acquired immunodeficiency syndrome in resource-limited settings. (2005) (52)
Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model (2017) (50)
The US COVID-19 Trends and Impact Survey: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing, and vaccination (2021) (50)
Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model (2018) (49)
Healthy life expectancy: comparison of OECD countries in 2001 (2003) (48)
National HIV prevalence estimates for sub-Saharan Africa: controlling selection bias with Heckman-type selection models (2012) (47)
The Use and Misuse of Mathematical Modeling for Infectious Disease Policymaking: Lessons for the COVID-19 Pandemic (2021) (47)
Keep it simple: ranking health states yields values similar to cardinal measurement approaches. (2009) (45)
Comparative Effectiveness of Personalized Lifestyle Management Strategies for Cardiovascular Disease Risk Reduction (2016) (45)
Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study (2017) (45)
The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models (2014) (44)
MEASURING PREFERENCES ON HEALTH SYSTEM PERFORMANCE ASSESSMENT (2000) (44)
Clinical Benefits, Costs, and Cost-Effectiveness of Neonatal Intensive Care in Mexico (2010) (44)
Mapping routine measles vaccination in low- and middle-income countries (2020) (44)
The conceptual basis for measuring and reporting on health (2002) (43)
Population health impact and cost‐effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China (2014) (42)
HIV Treatment as Prevention: Issues in Economic Evaluation (2012) (42)
Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care. (2019) (41)
The Household Secondary Attack Rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Rapid Review (2020) (40)
Modelling national HIV/AIDS epidemics: revised approach in the UNAIDS Estimation and Projection Package 2011 (2012) (38)
Cross-population comparability of evidence for health policy (2002) (38)
Cross-population comparability of self-reported and physician-assessed mobility levels: Evidence from the Third National Health and Nutrition Examination Survey (2001) (37)
Methods for life expectancy and healthy life expectancy uncertainty analysis (2001) (37)
Multimorbidity and care for hypertension, diabetes and HIV among older adults in rural South Africa (2018) (37)
Performance of self-reported HIV status in determining true HIV status among older adults in rural South Africa: a validation study (2017) (36)
Packaging Health Services When Resources Are Limited: The Example of a Cervical Cancer Screening Visit (2006) (36)
Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings. (2019) (36)
Prevalence and correlates of frailty in an older rural African population: findings from the HAALSI cohort study (2017) (36)
Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases (2017) (36)
Modeling Contact Tracing Strategies for COVID-19 in the Context of Relaxed Physical Distancing Measures (2020) (36)
Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction. (2021) (35)
ENHANCING CROSS-POPULATION COMPARABILITY OF SURVEY RESULTS (2001) (35)
Tracking population health based on self-reported impairments: Trends in the prevalence of hearing loss in US adults, 1976-2006. (2009) (33)
AN INDIVIDUAL-LEVEL APPROACH TO HEALTH INEQUALITY: CHILD SURVIVAL IN 50 COUNTRIES (2000) (32)
[Priority setting for health interventions in Mexico's System of Social Protection in Health]. (2007) (32)
Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations. (2017) (32)
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae (2021) (31)
HIV burden in men who have sex with men: a prospective cohort study 2007–2012 (2015) (31)
Quantifying Child Mortality Reductions Related to Measles Vaccination (2010) (30)
Evaluating the impact of antiretroviral therapy on HIV transmission. (2008) (30)
Flexible epidemiological model for estimates and short-term projections in generalised HIV/AIDS epidemics (2010) (30)
Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study (2018) (30)
Taking account of future technology in cost effectiveness analysis (2004) (30)
Who Needs Laboratories and Who Needs Statins?: Comparative and Cost-Effectiveness Analyses of Non–Laboratory-Based, Laboratory-Based, and Staged Primary Cardiovascular Disease Screening Guidelines (2014) (29)
Female Sex Workers Often Incorrectly Interpret HIV Self-Test Results in Uganda (2018) (29)
Bulletin of the World Health Organization (2022) (29)
Awareness, treatment, and control of dyslipidemia in rural South Africa: The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) study (2017) (29)
Partnering with a global platform to inform research and public policy making (2020) (29)
Inference With Difference-in-Differences With a Small Number of Groups: A Review, Simulation Study, and Empirical Application Using SHARE Data (2018) (28)
Estimating The Potential Impact Of Insurance Expansion On Undiagnosed And Uncontrolled Chronic Conditions. (2015) (28)
The impact of migration on tuberculosis in the United States. (2018) (28)
Cross-population comparability of physician-assessed and self-reported measures of health (2003) (28)
Spline-based modelling of trends in the force of HIV infection, with application to the UNAIDS Estimation and Projection Package (2012) (27)
Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV. (2007) (27)
Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)) (2017) (27)
Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: results of a Bayesian evidence synthesis model (2020) (26)
Estimating the distribution of morbidity and mortality of childhood diarrhea, measles, and pneumonia by wealth group in low- and middle-income countries (2018) (26)
Covid-19 Vaccine Acceptance in California State Prisons (2021) (26)
Quantifying and Benchmarking Disparities in COVID-19 Vaccination Rates by Race and Ethnicity (2021) (26)
Global Patterns of Healthy Life Expectancy for Older Women (2002) (26)
Summary measures of population health: conclusions and recommendations. (2002) (25)
Quantification of Health States with Rank-Based Nonmetric Multidimensional Scaling (2007) (25)
Hypertension management in a population of older adults in rural South Africa (2017) (25)
A model to forecast regional demand for COVID-19 related hospital beds (2020) (25)
The Estimation and Projection Package Age-Sex Model and the r-hybrid model: new tools for estimating HIV incidence trends in sub-Saharan Africa (2019) (24)
Sustainable Development in Surgery: The Health, Poverty, and Equity Impacts of Charitable Surgery in Uganda (2016) (23)
The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients (2014) (23)
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019 (2021) (23)
Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison (2021) (23)
[Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER Statement]. (2017) (23)
Infant mortality is not an adequate summary measure of population health (2003) (23)
Cost-effectiveness and budgetary impact of HCV testing, treatment and linkage to care in U.S. prisons. (2020) (22)
Disease burden and mental health system capacity: WHO Atlas study of 117 low- and middle-income countries (2012) (21)
Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States. (2021) (21)
Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies (2021) (21)
Passing the Test: A model-based analysis of safe school-reopening strategies (2021) (21)
Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs. (2013) (21)
Alternative summary measures of average population health (2003) (21)
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 (2021) (20)
Using interviewer random effects to remove selection bias from HIV prevalence estimates (2015) (20)
Assessing and adjusting for differences between HIV prevalence estimates derived from national population-based surveys and antenatal care surveillance, with applications for Spectrum 2013 (2014) (20)
Health gaps: an overview and critical appraisal. (2002) (20)
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. (2013) (20)
Defining high-value information for COVID-19 decision-making (2020) (19)
COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors (2021) (19)
Valuing Health Outcomes (2016) (19)
Costs and cost-effectiveness of a mental health intervention for war-affected young persons: decision analysis based on a randomized controlled trial. (2016) (19)
COVID-19 Policy Impact Evaluation: A guide to common design issues (2021) (19)
Disability weights for vision disorders in Global Burden of Disease study – Authors' reply (2013) (18)
The U.S. COVID-19 Trends and Impact Survey, 2020-2021: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing and vaccination (2021) (18)
The Effect of HIV and the Modifying Effect of Anti-Retroviral Therapy (ART) on Body Mass Index (BMI) and Blood Pressure Levels in Rural South Africa (2014) (18)
Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis (2019) (18)
Comparability of Patient-reported Health Status: Multicountry Analysis of EQ-5D Responses in Patients With Type 2 Diabetes (2011) (17)
Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England (2017) (17)
The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV. (2018) (17)
Decision Models in Cost-Effectiveness Analysis (2016) (16)
The Use of Mathematical Models of Chlamydia Transmission to Address Public Health Policy Questions: A Systematic Review (2017) (16)
Depressive Symptoms and Their Relation to Age and Chronic Diseases Among Middle-Aged and Older Adults in Rural South Africa. (2018) (16)
The Effect of HIV Self-Testing Delivery Models on Female Sex Workers’ Sexual Behaviors: A Randomized Controlled Trial in Urban Uganda (2019) (16)
Methods for modeling the HIV/AIDS epidemic in sub-Saharan Africa (1999) (15)
Measuring health and economic wellbeing in the Sustainable Development Goals era: development of a poverty-free life expectancy metric and estimates for 90 countries. (2018) (15)
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1 (2016) (14)
Correction: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement (2016) (14)
The Impact of Screening and Partner Notification on Chlamydia Prevalence and Numbers of Infections Averted in the United States, 2000–2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model (2019) (14)
Trading Bankruptcy for Health: A Discrete-Choice Experiment. (2018) (14)
Enlightened self-interest and the control of tuberculosis. (2005) (14)
Teenage smoking behaviour following a high-school smoking ban in Chile: interrupted time-series analysis (2015) (13)
Protection against Omicron from Vaccination and Previous Infection in a Prison System (2022) (13)
Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis (2015) (13)
Estimating health state valuations using a multiple-method protocol (2003) (13)
The effects of changes in distance to nearest health facility on under-5 mortality and health care utilization in rural Malawi, 1980–1998 (2020) (12)
Covid-19 in the California State Prison System: An Observational Study of Decarceration, Ongoing Risks, and Risk Factors (2021) (12)
Does incident circumcision lead to risk compensation? Evidence from a population cohort in KwaZulu-Natal, South Africa (2019) (12)
The impact of measurement differences on cross-country depression prevalence estimates: A latent transition analysis (2018) (12)
Exploring Model Uncertainty in Economic Evaluation of Health Interventions: The Example of Rotavirus Vaccination in Vietnam (2010) (11)
Long-term Disability Associated With War-related Experience Among Vietnam Veterans (2015) (11)
COMPOSITIONAL MODELS FOR MORTALITY BY AGE , SEX AND CAUSE (2001) (10)
Preferences for health outcomes associated with Group A Streptococcal disease and vaccination (2010) (10)
Improving outcomes for caregivers through treatment of young people affected by war: a randomized controlled trial in Sierra Leone (2015) (10)
Better Late Than Never: Trends in COVID-19 Infection Rates, Risk Perceptions, and Behavioral Responses in the USA (2021) (10)
HIV treatment cascade for older adults in rural South Africa (2019) (10)
Recommendations on Perspectives for the Reference Case (2016) (10)
PRE-PRINT: NOT PEER-REVIEWED (2021) (10)
Predictors of male circumcision incidence in a traditionally non-circumcising South African population-based cohort (2018) (9)
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. (2020) (9)
HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic (2020) (9)
Rationalizing Noneconomic Damages: A Health Utilities Approach (2011) (9)
A review of network simulation models of hepatitis C virus and HIV among people who inject drugs. (2019) (9)
Multimorbidity and mortality in an older, rural black South African population cohort with high prevalence of HIV findings from the HAALSI Study (2021) (9)
Global Patterns of Health Expectancy in the Year 2000 (2003) (9)
Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California. (2020) (9)
Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States (2020) (9)
Disability weights for infectious diseases in four European countries: comparison between countries and across respondent characteristics (2017) (9)
Erratum: GBD 2010 Country Collaboration. GBD 2010 country results: A global public good (The Lancet (2013) 381 (965-970)) (2013) (9)
How should HIV programmes respond to evidence for the benefits of earlier treatment initiation ? A combined analysis of twelve mathematical models (2013) (9)
Limitations of the UNAIDS 90-90-90 metrics: a simulation-based comparison of cross-sectional and longitudinal metrics for the HIV care continuum (2020) (9)
Passing the Test: A Model-Based Analysis of Safe School-Reopening Strategies (2021) (8)
SARS-CoV-2 testing strategies to contain school-associated transmission: model-based analysis of impact and cost of diagnostic testing, screening, and surveillance (2021) (8)
Is knowledge of HIV status associated with sexual behaviours? A fixed effects analysis of a female sex worker cohort in urban Uganda (2019) (8)
Estimated Impact of Screening on Gonorrhea Epidemiology in the United States: Insights From a Mathematical Model (2018) (8)
Erratum: Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1725–1774)(S0140673616315756)(10.1016/S0140-6736(16)31575-6)) (2017) (8)
Nationwide cost-effectiveness analysis of surgical stabilization of rib fractures by flail chest status and age groups (2020) (8)
Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States (2020) (8)
PHP27 HEALTH STATE VALUATIONS IN SUMMARY MEASURES OF POPULATION HEALTH (2002) (7)
Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study (2022) (7)
Measuring health state values in developing countries -- results from a community survey in Andhra Pradesh. (2002) (7)
World Mortality in 2000 (2002) (7)
The individual basis for summary measures of population health. (2002) (7)
Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic (2021) (7)
Population-level Benefits of Extragenital Gonorrhea Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis (2020) (7)
Uptake of COVID-19 Vaccination Among Frontline Workers in California State Prisons (2022) (7)
Impact of HIV on novel therapies for tuberculosis control (2008) (7)
Problems with Evidence Assessment in COVID-19 Health Policy Impact Evaluation: A systematic review of study design and evidence strength (2021) (7)
Policy evaluation in COVID-19: A guide to common design issues (6)
Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis. (2015) (6)
Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021 (2022) (6)
The Potential Population-Level Impact of Different Gonorrhea Screening Strategies in Baltimore and San Francisco: An Exploratory Mathematical Modeling Analysis (2019) (5)
Population Immunity to Pre-Omicron and Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Variants in US States and Counties Through 1 December 2021 (2022) (5)
Impact of Treatment Duration on Mortality Among Veterans with Opioid Use Disorder in the United States Veterans Health Administration. (2021) (5)
Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022 (2022) (5)
Expanding the WHO tuberculosis control strategy (1998) (5)
Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials (2020) (5)
Concordance between fasting plasma glucose and HbA1c in the diagnosis of diabetes in black South African adults: a cross-sectional study (2021) (5)
Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study (2020) (5)
How do Japanese rate the severity of different diseases and injuries?—an assessment of disability weights for 231 health states by 37,318 Japanese respondents (2021) (5)
Exploring How Epidemic Context Influences Syphilis Screening Impact: A Mathematical Modeling Study (2020) (5)
Designing a Cost-Effectiveness Analysis (2016) (5)
Practice of Epidemiology Impact Evaluation of Coronavirus Disease 2019 Policy: A Guide to Common Design Issues (2021) (5)
All‐cause versus cause‐specific excess deaths for estimating influenza‐associated mortality in Denmark, Spain, and the United States (2022) (4)
High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000–2016 (2020) (4)
EPP-ASM and the r-hybrid model: new tools for estimating HIV incidence trends in sub-Saharan Africa. (2019) (4)
Policy evaluation in COVID-19: A graphical guide to common design issues (2020) (4)
Disparities in Management of Cardiovascular Disease in Rural South Africa: Data From the HAALSI Study (Health and Aging in Africa: Longitudinal Studies of International Network for the Demographic Evaluation of Populations and Their Health Communities). (2017) (4)
Asymptomatic COVID-19 screening tests to facilitate full-time school attendance: model-based analysis of cost and impact (2021) (4)
Assessing the population health impact of market interventions to improve access to antiretroviral treatment (2011) (4)
Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease (2022) (4)
Identifying and Quantifying the Consequences of Interventions (2016) (4)
Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study. (2020) (4)
Federal Funding For State And Local Contact Tracing Efforts Is An Urgent Priority, And A Bargain (2020) (3)
Contact tracing strategies for COVID-19 containment with attenuated physical distancing (2020) (3)
Affordability and Value in Decision Rules for Cost-Effectiveness: A Survey of Health Economists. (2022) (3)
Non-monotonicity in the episodic random utility model. (2011) (3)
Progression from latent infection to active disease in dynamic TB transmission models: a systematic review of the validity of modelling assumptions (2017) (3)
Differences in healthy longevity by HIV status and viral load among older South African adults: an observational cohort modelling study. (2022) (3)
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study (2022) (3)
Developing and evaluating a frailty index for older South Africans—findings from the HAALSI study (2021) (3)
Ordinal Valuation of Health States: A Eight Country Comparison (2007) (3)
Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: Results of a Bayesian evidence synthesis model (2022) (3)
Cost-Effectiveness of Hepatitis B Testing and Vaccination of Adults Seeking Care for Sexually Transmitted Infections (2022) (3)
Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students. (2022) (3)
Estimation and correction of bias in network simulations based on respondent-driven sampling data (2020) (3)
Valuing Health States, Techniques for (2014) (3)
Metamodeling for Policy Simulations with Multivariate Outcomes (2022) (3)
A latent transition analysis for the assessment of structured diagnostic interviews. (2015) (3)
Mapping Inequality in SARS-CoV-2 Household Exposure and Transmission Risk in the USA (2021) (3)
Model-based estimates of deaths averted and cost per life saved by scaling-up mRNA COVID-19 vaccination in low and lower-middle income countries in the COVID-19 Omicron variant era (2022) (3)
Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination (2020) (2)
An evaluation of 6-month versus continuous isoniazid preventive therapy for M. tuberculosis in adults living with HIV/AIDS in Malawi. (2020) (2)
ORDINAL VALUATION OF HEALTH STATES : A SEVEN COUNTRY COMPARISON July 25 , 2006 (2008) (2)
Addressing racial/ethnic disparities in the COVID-19 vaccination campaign (2021) (2)
Quality Adjusted Life Years (2008) (2)
Modeling the Cost-Effectiveness of Express Multisite Gonorrhea Screening Among Men Who Have Sex With Men in the United States (2021) (2)
Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) Lost Due to Syphilis Acquired in the United States in 2018 (2022) (2)
Simple decision rules to predict local surges in COVID-19 hospitalizations during the winter and spring of 2022 (2021) (2)
Trends, Mechanisms, and Racial/Ethnic Differences of Tuberculosis Incidence in the US-Born Population Aged 50 Years or Older in the United States (2021) (2)
Dependence of COVID-19 Policies on End-of-Year Holiday Contacts in Mexico City Metropolitan Area: A Modeling Study (2021) (2)
Improving the Validity of Mathematical Models for HIV Elimination by Incorporating Empirical Estimates of Progression Through the HIV Treatment Cascade (2018) (2)
PMC29 INTERNATIONAL VALUATION SET FOR EQ-5D HEALTH STATES (2008) (2)
Integrating Economic Evaluation and Implementation Science to Advance the Global HIV Response. (2019) (2)
Eliciting national and subnational sets of disability weights in mainland China: Findings from the Chinese disability weight measurement study (2022) (2)
Patterns of heavy drinking behaviour over age and birth cohorts among Chinese men: a Markov model (2021) (2)
Adventures in COVID-19 Policy Modeling: Education Edition (2021) (2)
CC3 MEASURING POPULATION HEALTH FOR 191 COUNTRIES:WHO METHODS AND RESULTS (2002) (2)
A conceptual framework for understanding adaptation , coping and adjustment in health state valuations (2003) (2)
Improving Vignette Descriptions and Question Formats to Measure Distance Vision (2017) (2)
Problems with evidence assessment in COVID-19 health policy impact evaluation: a systematic review of study design and evidence strength (2022) (2)
Evaluating the Performance of Centers for Disease Control and Prevention COVID-19 Community Levels as Leading Indicators of COVID-19 Mortality (2022) (2)
The impact of Medicare part D on income-related inequality in pharmaceutical expenditure (2019) (2)
Using Interviewer Random Effects to Calculate Unbiased HIV Prevalence Estimates in the Presence of Non-Response: a Bayesian Approach (2013) (2)
Life expectancy in Seychelles – Authors' reply (2013) (1)
HIV burden in men who have sex with men: a prospective cohort study during 2007–12 in Beijing, China (2013) (1)
Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics (2022) (1)
Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi. (2020) (1)
MC8 COMPARING THE INTERVAL PROPERTIES OF HEALTH-STATE VALUATIONS MEASURED USING THE VISUAL ANALOGUE SCALE AND RANK-BASED SCALING (2004) (1)
Modelling hospital operations: insight from using data from paper registries in the obstetrics ward at a hospital in Addis Ababa, Ethiopia (2019) (1)
Measuring and correcting bias in indirect estimates of under-5 mortality in populations affected by HIV/AIDS: a simulation study (2019) (1)
Evidence sources on the natural history of latent tuberculosis infection. (2018) (1)
The Lifetime Burden of Disease Due to Incident Tuberculosis: A Global Re-Appraisal Including Post-TB Sequelae (2021) (1)
Adaptive policies for use of physical distancing interventions during the COVID-19 pandemic (2020) (1)
Refining global HIV estimates for decision‐making: advances in analytic and modelling methods used by the Joint United Nations Programme on HIV/AIDS (2021) (1)
Model-estimated relationship between elementary school-related SARS-CoV-2 transmission, mitigation interventions, and vaccination coverage across community incidence levels (2021) (1)
P3.16 Impact of rapid susceptibility profiling on the emergence and spread of antibiotic resistance in gonorrhoea (2017) (1)
The overlapping burden of the three leading causes of disability and death in sub-Saharan African children (2022) (1)
Department of Error (2017) (1)
Mathematical modeling study of school-based chlamydia screening: potential impact on chlamydia prevalence in intervention schools and surrounding communities (2020) (1)
Balancing health and financial protection in health benefit package design (2021) (1)
Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: A modelling study of overall burden and disparities by age, race/ethnicity, and other factors (2022) (1)
SUN-616 Poor Diagnostic Concordance Between Fasting Plasma Glucose and Glycosylated Hemoglobin in a Black South African Population (2020) (1)
P0798 : The cost-effectiveness of sofosbuvir- and simeprevirbased therapies for HCV genotype 1 infection (2015) (1)
Bodalla South Field (1990) (1)
Comparable measures of population health with a focus on OECD countries (2003) (1)
Cost-effectiveness of first-line therapy for advanced renal cell carcinoma in the immunotherapy era. (2020) (1)
A model to estimate regional demand for COVID-19 related hospitalizations (2020) (1)
Estimation and Projection Package 2007 country-level HIV/AIDS epidemics: the UNAIDS Progress and challenges in modelling (2009) (0)
Lifetime quality-adjusted life years lost due to genital herpes acquired in the United States in 2018: a mathematical modeling study (2023) (0)
Random Effects to Calculate Unbiased HIV Prevalence Estimates in the Presence of Non-Response : a Bayesian Approach September 2013 (2013) (0)
Vaccination in Vietnam Exploring Model Uncertainty in Economic Evaluation of Health Interventions : The Example of Rotavirus (2010) (0)
Feasibility of a Health‐Utility Approach to Quantifying Noneconomic Losses from Personal Injury (2018) (0)
Feasibility of a Health Utilities Approach for Quantifying Noneconomic Losses from Personal Injury (2015) (0)
of Healthy Life Expectancy for Older Women (2002) (0)
O14.1 Optimizing screening for chlamydia: is there a role for screening heterosexual men? (2019) (0)
Design and Analysis of Group-Randomized Trials: A Review of Recent Practices (2004) (0)
Assessing fitness-for-purpose and comparing the suitability of COVID-19 multi-country models for local contexts and users (2021) (0)
PIN22 - A PAYER PERSPECTIVE OF THE HOSPITAL INPATIENT ADDITIONAL CARE COSTS OF ANTIMICROBIAL RESISTANCE IN FRANCE: A MATCHED CASE-CONTROL STUDY (2018) (0)
PMC26 APPLICATION OFTHE FRAMEWORK FOR EVALUATING COMPLEX INTERVENTIONS TO CLUSTER RANDOMIZED TRIALS FOR THE EVALUATION OF DISEASE MANAGEMENT PROGRAMS (2010) (0)
Burden of infections related to antibiotic resistant bacteria in France in 2015: Results from the French Hospital discharge database (2018) (0)
Abstract 12318: A Cost-effectiveness Analysis of Ventricular Assist Devices (VAD) for the Treatment of Systolic Heart Failure in Pediatric Patients (2019) (0)
Health Disparities And COVID-19: The Authors Reply. (2021) (0)
The Future of TB in the United States : Going , or Growing ? (2012) (0)
Box 11.3, New Strategies for TB Diagnosis (2017) (0)
' s response to reviews Title : Cost-effectiveness of Rotavirus Vaccination in Vietnam (2008) (0)
Open vs Laparoscopic vs Robotic Surgery for Rectal Cancer: A Cost-Effectiveness Analysis (2019) (0)
Can bans break bad habits? An interrupted time series analysis of the impact of the 2005 high school smoking ban on teenage smoking behavior in Chile (2014) (0)
Erratum: Correction to Lancet HIV ((2016) 3 (e361–87)(S235230181630087X)(10.1016/S2352-3018(16)30087-X) (2016) (0)
Costs of routine care for chronic hepatitis C virus infection: the case of Illinois Medicaid (2016) (0)
The estimated lifetime quality-adjusted life-years lost due to chlamydia, gonorrhea, and trichomoniasis in the United States in 2018. (2023) (0)
Estimation and correction of bias in network simulations based on respondent-driven sampling data (2020) (0)
O01.6 Evaluating chlamydia trends in the united states 2000–2015 using a pair formation transmission model (2017) (0)
Response Incomparability in Self-Reported Mobility (2007) (0)
Population level outcomes and cost-effectiveness of expanding guidance for age-based hepatitis C testing in the United States (2017) (0)
Uptake of Covid-19 vaccines among frontline workers in California state prisons (2021) (0)
302. HCV Care in Federally Qualified Health Centers During the Opioid Epidemic: A Retrospective Cohort Study (2019) (0)
Quantification of Health States With Non-Metric Multidimensional Scaling (2007) (0)
PMC30 A REVIEW AND CRITIQUE OF METHODS FOR MEASURING TEMPORARY HEALTH STATES IN COST-UTILITY ANALYSES (2010) (0)
THE FIRST AUTHOR REPLIES (2009) (0)
Screening Adolescents and Young Adults for HIV in the United States: A Cost-Effectiveness Analysis (2017) (0)
Author's response to reviews Household and community socioeconomic and environmental determinants of child nutritional status Title: in Cameroon Authors: (2005) (0)
Original Contribution Are Americans Feeling Less Healthy? The Puzzle of Trends in Self-rated Health (2009) (0)
COMPUTER ASSISTED QUANTITATIVE EVALUATION OF THALLIUM 201 IMAGING BY REGIONAL SECTOR ANALYSIS WITH MYOCARDIUM ELLIPTICITY CORRECTION (1980) (0)
Research: Epidemiology Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: ﬁndings from the ADVANCE and ADVANCE-ON trials (2020) (0)
Comparability Problems in Culture-Fair Cognition Tests (2007) (0)
83 A Deficit Accumulation Frailty Index Predicts Mortality in Older South Africans: Findings from the HAALSI Study (2020) (0)
Generating simple classification rules to predict local surges in COVID-19 hospitalizations (2023) (0)
FOR MODELING THE HIV / AIDS EPIDEMIC IN SUB-SAHARAN AFRICA (2001) (0)
Survey Measurement for when ‘ You Know it When You See it ’ and Others See it Differently (2002) (0)
Costs, health benefits, and cost-effectiveness of chlamydia screening and partner notification in the United States, 2000-2019: a mathematical modeling analysis. (2023) (0)
Comparability of Self-Rated General Health: Findings from Five National U.S. Surveys (2007) (0)
Cost Effectiveness of Computed Tomography Versus Ultrasound-Based Surveillance Following Endovascular Aortic Repair of Intact Abdominal Aortic Aneurysms (2021) (0)
Reactor: A global perspective (2013) (0)
Health Can Be Measured (2020) (0)
Uncontrolled Chronic Conditions Estimating The Potential Impact Of Insurance Expansion On Undiagnosed And (2015) (0)
University of Birmingham Prevalence and correlates of frailty in an older rural African population (2017) (0)
How do Covid-19 policy options depend on end-of-year holiday contacts in Mexico City Metropolitan Area? A Modeling Study (2020) (0)
A Model for Estimating Future Risk of Fatal Coronary Heart Disease for Global Populations (USA). (2014) (0)
agree that further investigation of HCV infection-related qual- ity of life is a priority. (2017) (0)
Random Effects to Calculate Unbiased HIV Prevalence Estimates in the Presence of Non-Response : a Bayesian Approach February 2013 (2013) (0)
Cost effectiveness of computed tomography versus ultrasound-based surveillance following endovascular aortic repair of intact infrarenal abdominal aortic aneurysms. (2022) (0)
Machine Learning to Improve Meta-Modelling and Sensitivity Analysis: An HIV Case Study (2018) (0)
The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease (2021) (0)

This paper list is powered by the following services:

Other Resources About Joshua Salomon

en.wikipedia.org

What Schools Are Affiliated With Joshua Salomon?

Joshua Salomon is affiliated with the following schools: